Fairfield General Hospital is a hospital in Bury, Greater Manchester. It is managed by the Pennine Acute Hospitals NHS Trust.

During the past decade, Fairfield General Hospital conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 4 clinical trials were completed, i.e. on average, 23.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fairfield General Hospital" #1 sponsor was "Shire" with 3 trials, followed by "Abivax S.A." with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Intec Pharma Ltd." with 2 trials sponsored and "Ottawa Hospital Research Institute" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fairfield General Hospital" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "University Hospitals, Leicester" with 1 trials as a collaborator, "University of Manchester" with 1 trials as a collaborator, "University of Plymouth" with 1 trials as a collaborator and "University of Salford" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Fairfield General Hospital" are "Ulcerative Colitis" (7 trials), "Parkinson's Disease" (4 trials), "Parkinson Disease" (3 trials), "Asthma" (1 trials) and "Autism Spectrum Disorder" (1 trials). Many other conditions were trialed in "Fairfield General Hospital" in a lesser frequency.

Most popular intervention types in "Fairfield General Hospital" are "Drug" (16 trials), "Diagnostic Test" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Accordion Pill™ Carbidopa/Levodopa" (2 trials), "Ontamalimab" (2 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fairfield General Hospital" are 18 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Fairfield General Hospital". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 8 completed trials in Fairfield General Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fairfield General Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".